References
- Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3: 383−394, 2002 https://doi.org/10.1038/nrn812
- Airaksinen MS, Titievsky A, Saarma M. GDNF family neurotrophic factor signaling: four masters, one servant? Mol Cell Neurosci 13: 313−325, 1999 https://doi.org/10.1006/mcne.1999.0754
- Anderson RG. The caveolae membrane system. Annu Rev Biochem 67: 199−225, 1998 https://doi.org/10.1146/annurev.biochem.67.1.199
- Besset V, Scott RP, Ibanez CF. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J Biol Chem 275: 39159−39166, 2000 https://doi.org/10.1074/jbc.M006908200
- obola MS, Finn LS, Ellenbogen RG, Geyer JR, Berger MS, Braga JM, Meade EH, Gross ME, Silber JR. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Clin Cancer Res 11: 7405−7414, 2005 https://doi.org/10.1158/1078-0432.CCR-05-1068
-
Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P, Radice MT, Pierotti MA. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase C
$\gamma$ . Mol Cell Biol 16: 2151−2163, 1996 -
Cacalano G, Farinas I, Wang LC, Hagler K, Forgie A, Moore M, Armanini M, Phillips H, Ryan AM, Reichardt LF, Hynes M, Davies A, Rosenthal A. GFR
$\alpha$ 1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21: 53−62, 1998 https://doi.org/10.1016/S0896-6273(00)80514-0 - Chattopadhyay R, Das S, Maiti AK, Boldogh I, Xie J, Hazra TK, Kohno K, Mitra S, Bhakat KK. Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. Mol Cell Biol 28: 7066−7080, 2008 https://doi.org/10.1128/MCB.00244-08
- Chiarini LB, Freitas FG, Petrs-Silva H, Linden R. Evidence that the bifunctional redox factor / AP endonuclease Ref-1 is an anti-apoptotic protein associated with differentiation in the developing retina. Cell Death Differ 7: 272−281, 2000 https://doi.org/10.1038/sj.cdd.4400639
- Coulpier M, Anders J, Ibanez CF. Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase: importance of tyrosine 1062 for GDNF mediated neuronal differentiation and survival. J Biol Chem 277: 1991−1999, 2002 https://doi.org/10.1074/jbc.M107992200
- Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M. GDNF signalling through the Ret receptor tyrosine kinase. Nature 381: 789−793, 1996 https://doi.org/10.1038/381789a0
- Edwards M, Rassin DK, Izumi T, Mitra S, Perez-Polo JR. APE/Ref-1 responses to oxidative stress in aged rats. J Neurosci Res 54: 635−638, 1998 https://doi.org/10.1002/(SICI)1097-4547(19981201)54:5<635::AID-JNR8>3.0.CO;2-H
- Ernsberger U. The role of GDNF family ligand signalling in the differentiation of sympathetic and dorsal root ganglion neurons. Cell Tissue Res 333: 353−371, 2008 https://doi.org/10.1007/s00441-008-0634-4
- Fantini D, Vascotto C, Deganuto M, Bivi N, Gustincich S, Marcon G, Quadrifoglio F, Damante G, Bhakat KK, Mitra S, Tell G. APE1/Ref-1 regulates PTEN expression mediated by Egr-1. Free Radic Res 42: 20−29, 2008 https://doi.org/10.1080/10715760701765616
- Fishel ML, He Y, Reed AM, Chin-Sinex H, Hutchins GD, Mendonca MS, Kelley MR. Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth. DNA Repair (Amst) 7: 177−186, 2008 https://doi.org/10.1016/j.dnarep.2007.09.008
- Fung H, Demple B. A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. Mol Cell 17: 463−470, 2005 https://doi.org/10.1016/j.molcel.2004.12.029
- Fung H, Liu P, Demple B. ATF4-dependent oxidative induction of the DNA repair enzyme Ape1 counteracts arsenite cytotoxicity and suppresses arsenite-mediated mutagenesis. Mol Cell Biol 27: 8834−8847, 2007 https://doi.org/10.1128/MCB.00974-07
- Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380: 252−255, 1996 https://doi.org/10.1038/380252a0
- Hong M, Mukhida K, Mendez I. GDNF therapy for Parkinson's disease. Expert Rev Neurother 8: 1125−1139, 2008 https://doi.org/10.1586/14737175.8.7.1125
- Iwamori M, Shimomura J, Nagai Y. Specific binding of cholera toxin to rat erythrocytes revealed by analysis with a fluorescence- activated cell sorter. J Biochem 97: 729−735, 1985 https://doi.org/10.1093/oxfordjournals.jbchem.a135112
- Jiang Y, Guo C, Vasko MR, Kelley MR. Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res 68: 6425−6434, 2008 https://doi.org/10.1158/0008-5472.CAN-08-1173
- Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis JC, Hu S, Altrock BW, Fox GM. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85: 1113−1124, 1996 https://doi.org/10.1016/S0092-8674(00)81311-2
- Kim MH, Kim HB, Acharya S, Sohn HM, Jun JY, Chang IY, You HJ. Ape1/Ref-1 induces glial cell-derived neurotropic factor (GDNF) responsiveness by upregulating GDNF receptor alpha1 expression. Mol Cell Biol 29: 2264−2277, 2009 https://doi.org/10.1128/MCB.01484-08
- Kirik D, Georgievska B, Bjorklund A. Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat Neurosci 7: 105−110, 2004 https://doi.org/10.1038/nn1175
- Kisby GE, Milne J, Sweatt C. Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue. Neuroreport 8: 1337−1340, 1997 https://doi.org/10.1097/00001756-199704140-00004
- Klein SM, Behrstock S, McHugh J, Hoffmann K, Wallace K, Suzuki M, Aebischer P, Svendsen CN. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 16: 509−521, 2005 https://doi.org/10.1089/hum.2005.16.509
- Larsen E, Meza TJ, Kleppa L, Klungland A. Organ and cell specificity of base excision repair mutants in mice. Mutat Res 614: 56−68, 2007 https://doi.org/10.1016/j.mrfmmm.2006.01.023
- Lewen A, Sugawara T, Gasche Y, Fujimura M, Chan PH. Oxidative cellular damage and the reduction of APE/Ref-1 expression after experimental traumatic brain injury. Neurobiol Dis 8: 380−390, 2001 https://doi.org/10.1006/nbdi.2001.0396
- Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130−1132, 1993 https://doi.org/10.1126/science.8493557
- Liu H, Colavitti R, Rovira II, Finkel T. Redox-dependent transcriptional regulation. Circ Res 97: 967−974, 2005 https://doi.org/10.1161/01.RES.0000188210.72062.10
- McNeill DR, Lam W, DeWeese TL, Cheng YC, Wilson DM 3rd. Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites. Mol Cancer Res 7: 897−906, 2009 https://doi.org/10.1158/1541-7786.MCR-08-0519
- McNeill DR, Wilson DM 3rd. A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents. Mol Cancer Res 5: 61−70, 2007 https://doi.org/10.1158/1541-7786.MCR-06-0329
- Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, Phillips H, Reichardt LF, Ryan AM, Carver-Moore K, Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382: 76−79, 1996 https://doi.org/10.1038/382076a0
- Olkowski ZL. Mutant AP endonuclease in patients with amyotrophic lateral sclerosis. Neuroreport 9: 239−242, 1998 https://doi.org/10.1097/00001756-199801260-00012
- Ono Y, Matsumoto K, Furuta T, Ohmoto T, Akiyama K, Seki S. Relationship between expression of a major apurinic/apyrimidinic endonuclease (APEX nuclease) and susceptibility to genotoxic agents in human glioma cell lines. J Neurooncol 25: 183−192, 1995 https://doi.org/10.1007/BF01053151
-
Paratcha G, Ledda F. GDNF and GFR
$\alpha$ : a versatile molecular complex for developing neurons. Trends Neurosci 31: 384−391, 2008 https://doi.org/10.1016/j.tins.2008.05.003 -
Paratcha G, Ledda F, Baars L, Coulpier M, Besset V, Anders J, Scott R, Ibanez CF. Released GFR
$\alpha$ 1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 29: 171−184, 2001 https://doi.org/10.1016/S0896-6273(01)00188-X - Pichel JG, Shen L, Sheng HZ, Granholm AC, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382: 73−76, 1996 https://doi.org/10.1038/382073a0
- Pong K, Xu RY, Baron WF, Louis JC, Beck KD. Inhibition of phosphatidylinositol 3-kinase activity blocks cellular differentiation mediated by glial cell line-derived neurotrophic factor in dopaminergic neurons. J Neurochem 71: 1912−1919, 1998 https://doi.org/10.1046/j.1471-4159.1998.71051912.x
- Rass U, Ahel I, West SC. Defective DNA repair and neurodegenerative disease. Cell 130: 991−1004, 2007 https://doi.org/10.1016/j.cell.2007.08.043
- Saarma M, Sariola H. Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF). Microsc Res Tech 45: 292−302, 1999 https://doi.org/10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8
- Sakurai M, Nagata T, Abe K, Horinouchi T, Itoyama Y, Tabayashi K. Oxidative damage and reduction of redox factor-1 expression after transient spinal cord ischemia in rabbits. J Vasc Surg 37: 446−452, 2003 https://doi.org/10.1067/mva.2003.100
- Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382: 70−73, 1996 https://doi.org/10.1038/382070a0
- Sariola H, Saarma M. Novel functions and signalling pathways for GDNF. J Cell Sci 116: 3855−3862, 2003 https://doi.org/10.1242/jcs.00786
- Tan Z, Sun N, Schreiber SS. Immunohistochemical localization of redox factor-1 (Ref-1) in Alzheimer's hippocampus. Neuroreport 9: 2749−2752, 1998 https://doi.org/10.1097/00001756-199808240-00012
-
Tansey MG, Baloh RH, Milbrandt J, Johnson EM. GFR
$\alpha$ - mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival. Neuron 25: 611−623, 2000 https://doi.org/10.1016/S0896-6273(00)81064-8 - Tomac A, Lindqvist E, Lin LF, Ogren SO, Young D, Hoffer BJ, Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335−339, 1995 https://doi.org/10.1038/373335a0
- Treanor JJ, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature 382: 80−83, 1996 https://doi.org/10.1038/382080a0
- Tsui-Pierchala BA, Encinas M, Milbrandt J, Johnson EM. Lipid rafts in neuronal signaling and function. Trends Neurosci 25: 412−417, 2002 https://doi.org/10.1016/S0166-2236(02)02215-4
- Vasko MR, Guo C, Kelley MR. The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress. DNA Repair (Amst) 4: 367−379, 2005 https://doi.org/10.1016/j.dnarep.2004.11.006
- Walton M, Lawlor P, Sirimanne E, Williams C, Gluckman P, Dragunow M. Loss of Ref-1 protein expression precedes DNA fragmentation in apoptotic neurons. Brain Res Mol Brain Res 44: 167−170, 1997 https://doi.org/10.1016/S0169-328X(96)00291-4
- Wang D, Luo M, Kelley MR. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 3: 679−686, 2004
- Wilson TM, Rivkees SA, Deutsch WA, Kelley MR. Differential expression of the apurinic / apyrimidinic endonuclease (APE/ref-1) multifunctional DNA base excision repair gene during fetal development and in adult rat brain and testis. Mutat Res 362: 237−248, 1996 https://doi.org/10.1016/0921-8777(95)00053-4
- Xanthoudakis S, Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. Embo J 11: 653−665, 1992
- Xanthoudakis S, Smeyne RJ, Wallace JD, Curran T. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc Natl Acad Sci USA 93: 8919−8923, 1996 https://doi.org/10.1073/pnas.93.17.8919
- Xiang DB, Chen ZT, Wang D, Li MX, Xie JY, Zhang YS, Qing Y, Li ZP, Xie J. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo. Cancer Gene Ther 15: 625−635, 2008 https://doi.org/10.1038/cgt.2008.30
- Yang ZZ, Chen XH, Wang D. Experimental study enhancing the chemosensitivity of multiple myeloma to melphalan by using a tissue-specific APE1-silencing RNA expression vector. Clin Lymphoma Myeloma 7: 296−304, 2007 https://doi.org/10.3816/CLM.2007.n.006
Cited by
- GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance vol.19, pp.4, 2018, https://doi.org/10.3390/ijms19041078
- APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma vol.9, pp.11, 2009, https://doi.org/10.1038/s41419-018-1162-0